AGEING: Health Canada Recall

Health Canada Recalls

*Blood Pressure Medications Recalled Because of Contamination with Potential Carcinogen*

Users of blood pressure medications should contact their pharmacist if they need clarification about the medication they use.

Drug manufacturers are recalling several medications containing the ingredient valsartan, according to a press release from Health Canada.

The drugs being recalled are used to treat patients with high blood pressure to prevent heart attacks and stroke, and also for patients who have had heart failure or a recent heart attack.

An impurity, N-nitrosodimethylamine, was found in the valsartan used in these medications, supplied by a Chinese company, Zhejiang Huahai Pharmaceuticals. This substance is a potential carcinogen that could cause cancer over the long-term. Exposure to high levels of NDMA can also cause liver damage, according to the United States Environmental Protection Agency.

The European Medicines Agency is also reviewing the medication and there are recalls of these medications across Europe.

Health Canada advises consumers to keep taking their valsartan-containing medicine but to check with their pharmacist to see whether their medication is being recalled. If you are taking an affected medication, you should contact your health care practitioner as soon as possible to discuss your treatment options.

Here’s a list of the affected medications, provided by Health Canada. For a complete list including drug identification and lot numbers, visit their website:

• TEVA-VALSARTAN/HCTZ TABLETS PP 30s
• TEVA-VALSARTAN/HCTZ TABLETS (Bulk)
• ACT-VALSARTAN 40MG FC TABLETS 100
• ACT-VALSARTAN 80MG FC TABLETS 100
• ACT-VALSARTAN 160MG FC TABLETS 100
• SANDOZ VALSARTAN 40 MG
• SANDOZ VALSARTAN 80 MG
• SANDOZ VALSARTAN 160 MG
• SANDOZ VALSARTAN 320 MG
• SANIS VALSARTAN 40 MG
• SANIS VALSARTAN 80 MG
• SANIS VALSARTAN 160 MG
• PRO DOC LIMITEE VALSARTAN 40 MG
• PRO DOC LIMITEE VALSARTAN 80 MG
• PRO DOC LIMITEE VALSARTAN 160 MG
• PRO DOC LIMITEE VALSARTAN 320 MG
SIVEM PHARMACEUTICAL ULC VALSARTAN 40 MG
SIVEM PHARMACEUTICAL ULC VALSARTAN 80 MG
SIVEM PHARMACEUTICAL ULC VALSARTAN 160 MG
SIVEM PHARMACEUTICAL ULC VALSARTAN 320 MG

Global News website, July 10, 2018.

FOR MORE DETAILS ABOUT THIS RECALL, visit the HEALTH CANADA site at:
HEALTH CANADA RECALLS

Users of blood pressure medications should contact their pharmacist if they need clarification regarding the use of their medication.

This entry was posted in AGEING, HEALTH, SENIORS. Bookmark the permalink.

This site uses Akismet to reduce spam. Learn how your comment data is processed.